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Introduction

Schistosomiasis , a chronic dise as e c ause d by infe ction w ith the he lminths Schis to s o m a m a n s o n i, Schis tos o m a h a e m a to biu m or Schis to s o m a ja po n icu m
, pre sents a w orldw ide distribution and a varie d degre e of se verity.
1,2 S. m a n s o n i is the pre dominant schistosome found in the We ste rn w orld, apart from be ing also found in the Middle East and Afric a, 2 w hich induc es a disease of moderate se ve rity. 1 The se ve rity of schistosomiasis re lies on the modulation of a tissue granulomatous re sponse derive d from the re lease of adult w orm antigens in the host circ ulation as sociated w ith the slow re lease of larval-e gg c ross-re active antigens and subse que ntly by e gg-spec ific antige ns. 3 ,4 Soluble Egg Antigen or SEA is the te rm used to c ollec tively charac te rize the antigens re lease d by the eggs deposite d by Sch is to s o m a w orms in the tissue s and is composed by nine frac tions of prote ins w ith varie d profile of immunoge nicity. 4 The princ ipal sourc e of SEA is the skin of the embryo inside the egg, w hich at this stage , is calle d miracidium, although it c an also be re leased from the adult w orm and from c ercariae . 3 The host granulomatous re sponse to S. m a n s o n i infec tion in sensitive spec ie s can be dow n-modulate d by enhance d T-suppre ssor ce ll-activity and diminishe d CD4 + T-lymphoc yte re sponsivene ss ex p re sse d by re duction in cytokine re lease and lymphocyte p roliferation. 5 ,6 Curiously, it has be en demonstrate d that rats are re sistant 7 or 'non-p ermissible' 8 hosts to S. m a n s o n i infe ction.
In past years, SEA has be e n use d as a tool to study immune-me diate d inflammatory re actions 9 and the de ve lopme nt of a vacc ine against schistosomiasis mansoni has progressive ly be en appre ciate d. 1 0 -13 In the pre sent study, w e use d a pre paration of eggs and SEA from S. m a n s o n i inje cte d intrap lantarly to e valuate the mechanism of inflammation induce d in rat p aw s.
Materials and Methods
Animals
Holtzman female rats w e ighing 150-200 g w ere house d at 25± 3°C, under a 12 h light/dark cycle (lights on 07:00 h) w ith w ate r and food a d libitu m . Male albino Sw iss mic e w e re used as a sourc e of S. m a n s o n i eggs. In all ex periments, the numbe r of animals use d varie d be tw een 3 and 16.
Obtaining S. mansoni eggs and SEA S. m a n s o n i eggs w e re obtained from the liver of mic e infec te d w ith ce rc ariae 8 w e eks be fore , as pre viously desc ribe d. 1 4 The purified e ggs w ere fragmented in tissue grinders using phosphate -buffere d saline (PBS, 0.01 M, pH= 7.4). This proce dure de te rmined miracidium re lease thus facilitating the obtainm ent of SEA (Sch is to s o m a m a n s o n i Soluble Egg Antigen). The crude mate rial w as c entrifuged at 100 000 g for 2 h at 4°C. Various sup ernatants (SEA) w e re c ombined and e valuate d for protein conte nt by the Low ry method 1 5 and ke pt at -20°C until assayed. Only one pool of SEA has be e n used throughout the pre se nt studies.
Oedema measurements
Me as ure ments of the volume of rat p aw s w ere c arrie d out using a hydroplethysmomete r Ugo Basile (mode l 7150) be fore and afte r an intra plantar (i.pl.) inje ction of various doses of a suspension of S. m a n s o n i eggs (2000 e ggs/ml in PBS) or SEA dilute d in 0.1 ml of physiological saline at ze ro time . A sec ond inje ction of SEA (in 0.1 ml ste rile physiological saline ) w as also given 28 days later in the same paw w hene ver othe rw is e state d. The contralateral paw re ce ive d the same volume of ste rile physiologic al saline. Re sults are pre se nte d as the mean differe nc e be tw e en volume s (D V, m l) obtaine d from the paw s injecte d w ith eggs or SEA and those injec te d w ith saline ± standard error of the mean (SEM) in each group. In all the ex pe riments the measureme nts w ere obtaine d at 5, 15, 30, 60, 120, 240 min and 24 h follow ing intraplantar (i.pl.) inje ctions (n = 4 -13/group).
Selection of an inhibitory dose of an antibody against interleukin 1b (IL-1b )
To assess an inhibitory dose of an antib ody against human IL-1b , tw o dilutions (1/20 -1/200) of a comme rc ial pre paration of an antibody injecte d by subcutane ous (s.c.) route w ere te ste d in an assay of leukoc yte migration induc ed by intrape ritoneal (i.p.) injection of human IL-1b in rats. The te chnique use d to count leukoc ytes w as desc ribed e lsew here . 1 6 In the as say, it has be e n show n that 1.45 3 10 -1 0 M of human IL-1b incre ase d the rat pe ritoneal le ukoc yte number by 29% (P < 0.05, Anova t-te st, Fig. 1 ). A dilution of 1/20 of the antib ody re duce d the leukocyte c ounts inc re as ed by human IL-1b to the le ve l of control animals (> 99% re duc tion, Fig. 1 ), w here as a 1/200 dilution of the antibody did not significantly alter human IL-1b -induc ed e ffec t. The 1/20 dilution of the antibody w as used in rat paw s inje cte d w ith SEA for furthe r studies.
Experimental protocols
Four sets of ex periments w ere e stablishe d to e valuate the partic ipation of know n mediators re lease in the inflammation induc ed by e ggs or SEA from S. m a ns o n i in rat paw s. All antagonists used inhibite d at least 40% of the max imum oedematogenic e ffec t of their re spective agonists injecte d into the rat paw s and te ste d in parallel assays. In the case of HOE 140 (bradykinin antagonist), L-NAME (nitric ox ide synthas e inhibitor), indomethacin and dex amethasone (non-ste roidal and ste roidal anti-inflammatory drugs, re spective ly) the agonist used w as c arragee nin (250 m g/site). For pizotife n, pyrilamine and SR 140333 17 a dose of 5 m g of se rotonin (5-HT), 50 m g of histamine (H) and 50 m g of Substanc e P (SP), re spe ctively, w ere used p er site . In the first set, e ffec tive doses of pizotifen, pyrilamine, indomethacin or intramuscular (i.m.) dex amethasone w ere acute ly admin- -10 M. Dilutions of the antibody were also made in physiological saline. *Represents P < 0.05 (Anova t-test) compared with control animals (n=5-7).**Represents P < 0.01 from comparison with IL1b -injected animals (Anova t-test).
iste re d 30 min be fore i.pl. injection of SEA (time ze ro), as show n in a pre vious w ork. 1 8 The compound SR 140333 w as i.p . inje cte d 15 min be fore SEA. The inc re as e in paw volume w as obtain ed as de sc ribe d above during sensitization and challenge phase s. In the se cond se t of ex pe riments, pizotifen, dex ame thasone and indome thac in w ere acute ly administe re d by i.pl. route 30 min be fore challenge w ith SEA (10 m g/paw ). In the third se t, dex ame thasone and cyclosporin A (an immunosupp re ssive drug) w ere chronically administe re d by i.m. route from day 0 to day 14 follow ing SEA se nsitization (10 m g/paw ) and oedema me as ure ments w ere obtained after SEA challenge (10 m g/paw ). Finally, a 1/20 dilution of an antib ody against human IL-1b w as also administe re d by i.pl. route 15 min be fore SEA sensitization (10 m g/paw ) and the re sultant effe ct on SEA se nsitization (10 m g/paw ) w as also evaluate d. The dose of all drugs used w e re depic te d in the table s or figure lege nds . 
Histopathological studies
Drugs
Salts used in the pre sent w ork and the follow ing che micals w e re purchased from Sigma: pyrilamine, indomethac in, L-NAME, dex ame thasone , human interleukin 1b and anti-human IL-1b (de ve lope d in rabbit, IgG fraction). Pizotifen and c yclosporin A, SR140333 (a NK 1 -re ce ptor antagonist) and HOE 140 w ere kindly donate d by Flávio J. R. de Aguiar (Sandoz, Brazil), Xavie r Emonds-Alt (Sanofi, Montpellier) and Dr Mauro M. Te ix eira (Departamento de Farmacologia, ICB, UFMG), re spec tively.
Statistical analysis
The inc re ase in volume of rat paw s or pe ritoneal ce llular counts (mean ± standard e rror of the me an) follow ing administration of the agonists w he ther or not under diffe re nt treatments w ere compared w ith a control using Stude nt's t-te st for single c omparisons 
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or Anova for multiple comparisons. Analysis w as developed by the SigmaStat softw are, acc epting a value as statistical signific ant w he n P<0.05.
Results
Intraplantar administration of S. m a n s o n i e ggs (40 or 200 e ggs/0.1 ml) induc ed a dose -de pendent inc re ase in rat paw volume thus charac te rizing oe de ma formation w hich w as max imal at 120 min follow ing administration (0.27 ± 0.03 ml), re maine d significantly ele vated by 240 min (0.25 ± 0.02 ml; Fig. 2A ) and subsided 24 h later (data not show n). A sec ond injection of 200 e ggs in the same paw 28 days late r induc ed an inc re as ed oedematogenic re sponse at 15 min follow ing injection (0.75 ± 0.15 ml; Fig. 2B ), w hich w as re produce d if 10 m g SEA w as used inste ad of S. m a n s o n i eggs in the challenge (0.89 ± 0.10; Fig.  2C ). Se nsitization of rats w ith SEA also induce d oedema w hich w as max imal 15 -30 min follow ing injection and laste d for 4 h, dep ending on the dose used (Fig. 3) . No oedema w as de te c te d follow ing i.pl. injection of SEA afte r 24 h (Fig. 3) . How ever, the oedematogenic activity of SEA w as progre ssively decre as ed during the development of the ex perime nts. Such variation is illustrated in the c olumn of control re sults in Table 1 . The ac ute oe de ma follow ing SEA sensitization of rats w as 60% re duced by pre vious syste mic administration of pizotife n (2 mg/kg) s.c., but it w as not modified by effe ctive anti-oedemage nic doses of pyrilamine (2 mg/kg) s.c., SR 140333 (1 mg/ kg) i.p ., indome thacin (2 mg/kg) s.c ., L-NAME (0.5 mg/kg) s.c ., or dex ame thasone (1 mg/kg) i.m. (Table 1 ). In addition, the inc re as ed oe de matoge nic effect pre sented by the latte r animals to SEA challe nge w as not modified 28 days later (data not show n). Challe nge of animals w ith 1 or 10 m g SEA induc ed a dose-depende nt inc re ase of the oe de matoge nic re sponse in animals pre viously se nsitized w ith 10 m g SEA (Table 2) higher dose s of SEA w e re use d in se nsitization, as show n in Table 2 . This se condary oedema w as also 57% re duc ed by ac ute local tre atment of the paw s w ith pizotifen (100 m g/site ), but not w ith the same dose of indomethacin or dex amethas one ( Table 3) , re spe ctive ly, the oedematogenic re sponse on SEA challenge , i.e . 14 days later (Table 4) . Observation of the animals tre ate d w ith such dose s on sensitization (day 0) did not change the immediate follow ed oe de matoge nic re sponse (data not show n). Ac ute treatme nt of rat paw s w ith an antib ody anti-human IL-1b re duced by 48% the oedematogenic re sponse induce d by SEA on se nsitization of rat paw s (Fig. 4) .
Discussion
De velopment of schistosomiasis , a parasitic disease due to the Tre matoda Schis to s o m a m a n s o n i, is highly dep endent on the antigen burde n de rive d either from the adult w orms pre se nt in the c irculation or from the e ggs usually deposite d in the liver of the host. 8 The substanc es ex tracte d from the eggs of S. m a n s o n i are colle ctive ly name d by SEA 4 w hich se ems to be the main induc er of a modulate d re sponse in the chronic phase (granulomatous) of the dise ase , 5,1 9 In addition, SEA has be en use d as a
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Mediators of Inflammation · Vol 7 · 1998 265 tool to unde rstand the mechanisms of dise as e involving the immune syste m in ex perime ntal studies. 9 In the pre se nt w ork, w e have show n that S. m a n s o n i eggs induc ed inflammation in rat pads, and that SEA re produc ed the oe de matoge nic e ffec t of the inje ction of S. m a n s o n i e ggs, thus demons tratin g that the main oedematogenic e ffec t derived from eggs is due to SEA. We have also show n that SEA induce d an inc re as ed oe de matoge nic re sponse on a sec ond administration to the animals (challenge), afte r a period of 28 days, suggesting the involvement of the immune syste m in the latter re sponse. A surprising observation, how e ver, w as that the involveme nt of the immune syste m w as loc al rather than syste mic, sinc e the incre as ed effe ct on SEA challenge w as only observe d if the antige n w ere inje cte d in the same loc ation of the se nsitization, i.e. into the ipsilateral paw. This re sult suggeste d that (1) SEA is a w eak antigen, or conve rse ly, rats re strain very e ffec tively the immune re sponse to it, and (2) SEA is very easily cleared out of the animal bodies, unless it is continuously de livere d from the e ggs into the c irculation, as it happens during the c ourse of the diseas e in se nsitive sp ecie s. Irrespe ctive of the inc re ase in polymorphonuclear and mononuclear ce lls (mac rophage s and lymphocytes) into the rat paw s, as show n by histopathological studie s, the cellular sourc e of the 'local' immune re sponse to SEA w as not addre sse d in the pre sent w ork. It w as e stablishe d at le as t 30 ye ars ago by Parrat and West 20 that se rotonin (5-HT) w as the main inflammatory mediator re le as ed in rat pads. In fac t, here w e demonstrate d that serotonin accounte d for 60% and 57% of the oe de matoge nic re sp onse to SEA in se nsitization and challenge of rat paw s, re spec tively, sinc e pizotifen, a 5-HT 2 antagonist, 2 1 blocke d both syste mic ally and loc ally the re sponse . The re lease of other vasoactive substance s by SEA, such as bradykinin, histamine , substanc e P, prostaglandins, le ukotriene s, nitric ox ide or plate let activating factor (PAF) w as discarde d, since pre vious acute administration of their spec ific antagon ists or synthesis inhibitors have not modified the oedematogenic re sponse observe d follow ing SEA se nsitization. There fore , it w as re asonable to suppose that the early serotonin re lease (by 15 min) induc ed vasodilation and inc re ased vasc ular permeability and together w ith IL-1 (see be low ) contribute d to the arrival of circulating leukocyte s to the paw tissue show n in later times by histopathologic al studies. As those treatme nts have not modifie d the oedematogenic re sponse to SEA observe d on challenge , w e could also c onclude that all the me diators above mentione d w ere not important in the pathophysiology of the latte r re sponse . Howe ve r, to our know le dge , it is the first demonstration of an oe de matoge nic effe ct w hich w as not ac utely se nsitive to the pote nt and efficacious ste roidal antiinflammatory drug dex amethas one .
The particip ation of cytokines in the inflammatory re action due to SEA has be en re ported elsew here . 4,1 2 Our data support the notion that the oe de matoge nic effect induc ed by SEA in challe nge is immune -de rive d and depe nds on the re lease of c ytokines in early stages of the re action. Basic ally, thre e arguments favour our hypothesis : (1) a second injection of the antigen induc ed a pote ntiate d oe de matoge nic re sponse; (2) drugs w ith immunosuppre ssive ac tivity, such as dex ame thasone and c yclosp orin chronic ally administe re d during the early stage s of the re action gre atly re duce d (> 50%) the oedematogenic e ffec t observe d in challe nge; and (3) an antib ody spec ific against IL-1b w as e ffec tive in inhibiting by approximately 50% the oe de matoge nic re sponse to SEA. It has be en ex haustive ly show n that dex amethasone and cyclosporin are able to inhibit the synthesis / re lease of various cytokines, spe cially interle ukin-1 and 2, 2 2,2 3 the mainstay c ytokines involve d in the proce ssing of immune re sponse s. 2 4,2 5 As an antibody spe cific to human IL-1b signific antly blocked the oedema from 1 to 4 h of SEA se nsitization of rat paw s by ap prox imately 50%, it w as conclude d that IL-1 w as an important effe ctor of the pathophysiology of this oedema. In such case, IL-1 could e ffec t this re sponse through re c ruitment and activation of leukoc ytes as observe d by the arrival of these c ells to paw tissue from 2 h of SEA inje ctions as confirme d by histopathologic al studies. As dex amethasone treatme nt of rat paw s be fore SEA sens itization did not modify the early oedematogenic re spons e, it w as concluded that the dete cte d re duc tion of the oe de ma by the antibody during sens itization w as , at least partially, due to its binding to a pre formed IL-1, eventually the biologic al/ immunologic al analogous of IL-1b , IL-1a . 2 4 In addition, IL-1 c ould be acting as an important effe ctor of othe r re actions of the immune re sponse to SEA, such as the activation and prolife ration of T-ce ll lines, sinc e the pote ntiated oedematogenic re sponse on SEA challe nge w as observed just in a narrow dose range (1-10 m g). It might be emphasize d that, although w e have used a human IL-1b and a antib ody anti-human IL-1b in rats, the migration of le ukocyte and its blockade by the antib ody w ere ve ry consiste nt (29% inc re as e and > 99% inhibition, re spec tively), suggesting that the site of interac tion be tw een IL-1 and the host is re latively indepe nde nt of its source and w as cons erved in the evolution. Our data have strongly suggeste d that interle ukin 2 is involved in the proce ssing of the immune re sponse to SEA in rats, sinc e e arly treatme nt of the sensitize d animals w ith cyclosporin, as w ith dex ame thasone , gre atly inhibite d the oedematogenic re sponse on challenge (> 50%). Assuming that interle ukin-2 is re lease d by SEA, it is te mpting to sp eculate that the immune re sponse derive d from SEA injec tion in this spec ie s might involve pre dominantly the differe ntiation of the lymphoc ytes into a Th1 subset, rather than a Th2 subse t. 2 6,2 7 If it is so, other c ytokine s such as inte rferon gamma and interle ukin 12 (IL-12) may e ve ntually be dete cte d in this mode l. Rec ent pap ers have show n that ex ogenous IL-12 can inc re ase vaccine-induc ed immunity to S. m a n s o n i in mic e. 1 1,2 8 There fore , the as sociation of IL-12 re le as e w ith a ve ry effective immune re spons e induce d by IL-1 and IL-2, as suggeste d by our re sults, c ould ex plain at least in part, the re sistanc e of rats to S. m a n s o n i infe ction.
